FAGOTTO study
- Conditions
- Diabetes Mellitus, Type 2D003924
- Registration Number
- JPRN-jRCTs041200069
- Lead Sponsor
- Maruyama Shoichi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
patients with stable type 2 diabetes
-eGFR(Crteatinine)<= 60mL/min/1.73m2
-patients who are taking renin angiotensin system inhibitors (exclude intolerable or non-adaptive)
-older than 18 years
-written consent
-SGLT2 inhibitors users within 8 weeks
-30-under maintenance dialysis therapy or history of kidney plantation
-diuretics users
-patients who are taking both ACEi and ARB (renin inhibitor)
-active nephritis or kidney disease
-obvious steroid diabetes
-patients whose ALT and AST levels exceed 2.0 times the facility standard value
-heart failure NYHA class 4
-pregnant, or desiring to bear children
-inapporopriate for this study as judged by attending investigateor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method